title: Editorial: long-term safety and efficacy of certolizumab pegol for Crohn's disease.
authors.affiliation: Dipartimento di Medicina Interna e Specialità Mediche, Sapienza University of Rome, Rome, Italy. cesarini.monica@yahoo.it.
authors.forename: M
authors.initials: M
authors.lastname: Cesarini
authors.forename: S
authors.initials: S
authors.lastname: Danese
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007140:Immunoglobulin Fab Fragments; D007166:Immunosuppressive Agents; D011092:Polyethylene Glycols